Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Rhythm Pharmaceuticals Inc
About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company's lead asset, IMCIVREE, is an MC4R agonist designed to treat hyperphagia and severe obesity, is approved by the Food and Drug Administration (FDA) to reduce excess body weight and maintain reduction long term in adults and pediatric patients aged four years and older with acquired hypothalamic obesity, adult and pediatric patients two years of age and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency. In addition to it the Company is advancing a broad clinical development program for setmelanotide in other rare diseases, as well as investigational MC4R agonists bivamelagon and RM-718, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism.
Find out what a historical investment in Rhythm Pharmaceuticals Inc would be worth today using our RYTM stock calculator.
Market Capitalisation
$6.20B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
576.72K
High today
$92.65
Low today
$89.74
Open price
$92.21
52-week high
$122.20
52-week low
$57.20
Ready to start your investing journey with Stake?
Open an accountHow do I buy RYTM shares in Australia?
Buying RYTM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rhythm Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RYTM
What is the ticker symbol of Rhythm Pharmaceuticals Inc?
The ticker symbol for Rhythm Pharmaceuticals Inc is RYTM.
How much is one share of RYTM?
One share of RYTM is valued at $90.10 as of 16 May 2026.
What is the market capitalisation of Rhythm Pharmaceuticals Inc RYTM?
As of 16 May 2026 Rhythm Pharmaceuticals Inc has a market cap of $6.20B.
What is the 52-week high for Rhythm Pharmaceuticals Inc stock?
The Rhythm Pharmaceuticals Inc 52-week high stock price is $122.20.
What is the 52-week low for Rhythm Pharmaceuticals Inc stock?
The Rhythm Pharmaceuticals Inc 52-week low stock price is $57.20.
Can I buy RYTM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RYTM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RYTM on Stake
- Buy RYTM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RYTM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RYTM related stocks